Future directions for immunotherapy in meningioma treatment
Oncotarget
.
2021 Oct 26;12(22):2300-2301.
doi: 10.18632/oncotarget.27994.
Authors
John W Rutland
,
Jonathan T Dullea
,
Raj K Shrivastava
PMID:
34733420
PMCID:
PMC8555681
DOI:
10.18632/oncotarget.27994
No abstract available
Keywords:
immunotherapy; meningioma; molecular genetics.
Publication types
Editorial